Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxel

✍ Scribed by Carolien P. Schröder; Linda de Munck; Anneke M. Westermann; Willem M. Smit; Geert-Jan M. Creemers; Hiltje de Graaf; Jacqueline M. Stouthard; Gert van Deijk; Zoran Erjavec; Aart van Bochove; Willemijn Vader; Pax H. Willemse

• Book ID: 116430649
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 255 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2010.12.018